0% found this document useful (0 votes)
27 views7 pages

Afreen Test

The document is a medical test report for Ms. Afreen Hassan, a 28-year-old female, collected on June 2, 2023. It includes results from various tests such as Complete Blood Count, Liver & Kidney Panel, Lipid Screen, and HbA1c, with several values falling outside the normal reference intervals. The report is marked as interim and processed at Dr. Lal Path Labs in Srinagar, J&K.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
27 views7 pages

Afreen Test

The document is a medical test report for Ms. Afreen Hassan, a 28-year-old female, collected on June 2, 2023. It includes results from various tests such as Complete Blood Count, Liver & Kidney Panel, Lipid Screen, and HbA1c, with several values falling outside the normal reference intervals. The report is marked as interim and processed at Dr. Lal Path Labs in Srinagar, J&K.
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 7

.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:29PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar, J&K -
190018

Test Report
Test Name Results Units Bio. Ref. Interval

SwasthFit Super 4

COMPLETE BLOOD COUNT;CBC


(Electrical Impedence,Manual)

Hemoglobin 14.40 g/dL 12.00 - 15.00

Packed Cell Volume (PCV) 44.00 % 36.00 - 46.00

RBC Count 4.86 mill/mm3 3.80 - 4.80

MCV 91.00 fL 83.00 - 101.00

MCH 29.60 pg 27.00 - 32.00

MCHC 32.70 g/dL 31.50 - 34.50

Red Cell Distribution Width (RDW) 12.90 % 11.60 - 14.00

Total Leukocyte Count (TLC) 4.00 thou/mm3 4.00 - 10.00

Differential Leucocyte Count (DLC)


Segmented Neutrophils 47.40 % 40.00 - 80.00
Lymphocytes 42.20 % 20.00 - 40.00
Monocytes 6.60 % 2.00 - 10.00
Eosinophils 3.80 % 1.00 - 6.00
Basophils 0.00 % <2.00
Absolute Leucocyte Count
Neutrophils 1.90 thou/mm3 2.00 - 7.00
Lymphocytes 1.69 thou/mm3 1.00 - 3.00
Monocytes 0.26 thou/mm3 0.20 - 1.00
Eosinophils 0.15 thou/mm3 0.02 - 0.50
Basophils 0.00 thou/mm3 0.02 - 0.10
Platelet Count 127 thou/mm3 150.00 - 410.00

Mean Platelet Volume 11.0 fL 6.5 - 12.0

Note

*431169274* Page 1 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:29PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar, J&K -
190018

Test Report
Test Name Results Units Bio. Ref. Interval
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

*431169274* Page 2 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:36PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar,
J&K - 190018

Test Report

Test Name Results Units Bio. Ref. Interval

LIVER & KIDNEY PANEL, SERUM


(Spectrophotometry, Indirect ISE)

Bilirubin Total 0.68 mg/dL 0.30 - 1.20

Bilirubin Direct 0.12 mg/dL <0.30

Bilirubin Indirect 0.56 mg/dL <1.10

AST (SGOT) 44.0 U/L <35

ALT (SGPT) 85.0 U/L <35

GGTP 30.0 U/L <38

Alkaline Phosphatase (ALP) 72.00 U/L 30 - 120

Total Protein 7.80 g/dL 6.40 - 8.30

Albumin 4.81 g/dL 3.50 - 5.20

A : G Ratio 1.61 0.90 - 2.00

Urea 23.00 mg/dL 17.00 - 43.00

Creatinine 1.00 mg/dL 0.51 - 0.95

Uric Acid 6.90 mg/dL 2.60 - 6.00

Calcium, Total 9.79 mg/dL 8.80 - 10.60

Phosphorus 2.62 mg/dL 2.40 - 4.40

Sodium 136.00 mEq/L 136.00 - 146.00

Potassium 4.69 mEq/L 3.50 - 5.10

Chloride 104.00 mEq/L 101.00 - 109.00

ADVICE: CKD RISK MAP


KDIGO guideline, 2012 recommends Chronic Kidney disease (CKD) should be classified based on cause,
GFR category and albuminuria (ACR) category. GFR & ACR category combined together reflect risk of

*431169274* Page 3 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:36PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar,
J&K - 190018

Test Report

Test Name Results Units Bio. Ref. Interval


progression and helps clinician to identify individuals who are progressing at more rapid rate than anticipated

LIPID SCREEN, SERUM


(Enzymatic)

Cholesterol, Total 231.00 mg/dL <200.00

Triglycerides 180.00 mg/dL <150.00

HDL Cholesterol 55.00 mg/dL >50.00

LDL Cholesterol, Calculated 140.00 mg/dL <100.00

VLDL Cholesterol,Calculated 36.00 mg/dL <30.00

Non-HDL Cholesterol 176 mg/dL <130

Interpretation
------------------------------------------------------------------------------------------------
| REMARKS | TOTAL CHOLESTEROL | TRIGLYCERIDE | LDL CHOLESTEROL | NON HDL CHOLESTEROL |
| | in mg/dL | in mg/dL | in mg/dL | in mg/dL |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Optimal | <200 | <150 | <100 | <130 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Above Optimal | - | - | 100-129 | 130 - 159 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Borderline High | 200-239 | 150-199 | 130-159 | 160 - 189 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| High | >=240 | 200-499 | 160-189 | 190 - 219 |
|-------------------|--------------------|---------------|-----------------|---------------------|
| Very High | - | >=500 | >=190 | >=220 |
------------------------------------------------------------------------------------------------
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. NLA-2014 recommends a complete lipoprotein profile as the initial test for evaluating cholesterol.
3. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL
4. NLA-2014 identifies Non HDL Cholesterol(an indicator of all atherogeniclipoproteins such as LDL ,
VLDL, IDL, Lpa, Chylomicron remnants)along with LDL-cholesterol as co- primary target for
cholesterol lowering therapy. Note that major risk factors can modify treatment goals for LDL &Non
HDL.

*431169274* Page 4 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:36PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar,
J&K - 190018

Test Report

Test Name Results Units Bio. Ref. Interval


5. Apolipoprotein B is an optional, secondary lipid target for treatment once LDL & Non HDL goals have
been achieved
6. Additional testing for Apolipoprotein B, hsCRP,Lp(a ) & LP-PLA2 should be considered among patients
with moderate risk for ASCVD for risk refinement

Treatment Goals as per Lipid Association of India 2016


----------------------------------------------------------------------------------------------
| RISK | TREATMENT GOAL | CONSIDER THERAPY |
| CATEGORY |-----------------------------------------|-----------------------------------------|
| | LDL CHOLESTEROL | NON HDL CHLOESTEROL | LDL CHOLESTEROL | NON HDL CHLOESTEROL |
| | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) |
|----------|------------------|----------------------|------------------|----------------------|
| Very | <50 | <80 | >=50 | >=80 |
| High | | | | |
|----------|------------------|----------------------|------------------|----------------------|
| High | <70 | <100 | >=70 | >=100 |
|----------|------------------|----------------------|------------------|----------------------|
| Moderate | <100 | <130 | >=100 | >=130 |
|----------|------------------|----------------------|------------------|----------------------|
| Low | <100 | <130 | >=130* | >=160* |
----------------------------------------------------------------------------------------------

*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months

*431169274* Page 5 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:46PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar, J&K -
190018

Test Report

Test Name Results Units Bio. Ref. Interval


HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)

HbA1c 5.4 % 4.00 - 5.60

Estimated average glucose (eAG) 108 mg/dL

Interpretation
HbA1c result is suggestive of non diabetic adults (>=18 years)/ well controlled Diabetes in a known Diabetic

Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.

---------------------------------------------------------------------------------
| FACTORS THAT INTERFERE WITH HbA1C | FACTORS THAT AFFECT INTERPRETATION |
| MEASUREMENT | OF HBA1C RESULTS |
|--------------------------------------|------------------------------------------|
| Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte |
| hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte |
| modified derivatives of hemoglobin | age (e.g.,recovery from acute blood loss,|
| (e.g. carbamylated Hb in patients | hemolytic anemia, HbSS, HbCC, and HbSC) |
| with renal failure) can affect the | will falsely lower HbA1c test results |
| accuracy of HbA1c measurements | regardless of the assay method used.Iron |
| | deficiency anemia is associated with |
| | higher HbA1c |
---------------------------------------------------------------------------------

*431169274* Page 6 of 7
.

Name : Ms. AFREEN HASSAN


Lab No. : 431169274 Age : 28 Years
Ref By : Dr. MOHAMMAD ASHRAF KAR Gender : Female
Collected : 6/2/2023 12:38:00PM Reported : 6/2/2023 6:21:53PM
A/c Status : P Report Status : Interim
Collected at : Waterhail-CC Budgam Processed at : Dr Lal Path Labs
Bemina Degree College Road, Srinagar,
J&K - 190018

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA


(Hexokinase)

Glucose Fasting 97.00 mg/dL 70.00 - 100.00

Dr Adil Sidique Dr.Sameena Bashir Surma Dr.Shazia Bashir


MD, Pathology MD,Pathology MD,Pathology
Chief of Laboratory Consultant Pathologist Chief of Laboratory
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd

AHEEEHAPMKHJBIGNLCIBAJLCBILLJCECCJKCIKPJNKEDFJFAPPAHEEEHA
BNFFFNBPAPBOBPBGFGEGIGAPAOAHFHALAGJOBCJCJLEKMCJHMPBNFFFNB
CIEGFCFJNOPPGNJOPFIAAJHFJCHEHEDHPKPHENFLMLKIOEFLBLHDEHANP
DJPPKAFNBBCIEDIEMLNELFMFANPLAKAFJIFFOBPAKCLJPDNLINFBKEMEK
KCPHLHFJOBFFDIAOOCECKPJBDENHMDCHKKMDAAGIPLKGKPNGKFFFOIKJG
FICBBEFNMICGDLEKIDIPLIPBADHFOFAINDFCBKDLALIKOMNALNEJOOMCL
DLIMIJFFELOCIPCIEKMIJEFHIHAFJBAKOFMPBLMEOJCHKJNKIJNJIDILD
NJJJAMFMALNDOAPJGANHDNGILLBMFMBLKFCCAMNNIIKNOPNOBNFNBHILL
NKCHHKFCNPHGFAAKJPNIHIMKHMCFEKFBJFFKBLPFOOBIOCNKDJPHNEKLJ
OMFCPFFCEHNJJDCDJKEFGPNIADFKPNJHKEPLGDFLNKCKIGEOCHOKHJCJP
LEIKOLFLGKCBMPBMPFJMAJEEINMGFJFBJMFEBFOFPNDMKPFKEPCIGCIEG
IGICGJFCPLDIKGKMHHGJMPCEIEOPPFOEAOFPBLNOOLJBIKNIOKONHDICL
MNNNNNEHKGBIMGCJOCFLHLEHJBAHFHANPKPFCMNLMKJCLFNKAHFHAHIKL
APBBBPAPBNPAEJBJENDKCFGFAGHCHHCAONFFPKPGOLMHNLNNEDFFDBKHH
HHHHHHHPHHPPHPPPPPHPPPHHPPPPPPPPPPPHHPHPPHHHPHPHHHHPPHPHP

Result/s to follow:
THYROID PROFILE,TOTAL, SERUM, VITAMIN B12; CYANOCOBALAMIN, SERUM, VITAMIN D, 25 - HYDROXY, SERUM

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner/Doctor. ŸThe report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: lalpathlabs@lalpathlabs.com

*431169274*
Page 7 of 7

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy